BRAF and melanoma: Thus, the mutational profile of melanomas varies with age, so older patients tend to have more NRAS (NRAS proto-oncogene GTP-ase/Neuroblastoma RAS Viral (v-ras) Oncogene Homolog) mutations, while younger have more BRAF mutations [80].